A detailed history of New York State Common Retirement Fund transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 13,104 shares of AURA stock, worth $130,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,104
Previous 6,504 101.48%
Holding current value
$130,646
Previous $49,000 138.78%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$6.9 - $10.36 $45,540 - $68,376
6,600 Added 101.48%
13,104 $117,000
Q2 2024

Jul 31, 2024

BUY
$6.81 - $7.89 $490 - $568
72 Added 1.12%
6,504 $49,000
Q1 2024

May 07, 2024

SELL
$7.09 - $9.24 $85 - $110
-12 Reduced 0.19%
6,432 $50,000
Q4 2023

Feb 01, 2024

SELL
$7.02 - $11.98 $308 - $527
-44 Reduced 0.68%
6,444 $57,000
Q3 2023

Nov 07, 2023

BUY
$8.97 - $12.38 $870 - $1,200
97 Added 1.52%
6,488 $58,000
Q2 2023

Aug 07, 2023

SELL
$8.51 - $13.33 $61,025 - $95,589
-7,171 Reduced 52.88%
6,391 $79,000
Q1 2023

May 02, 2023

SELL
$8.88 - $12.11 $7,992 - $10,899
-900 Reduced 6.22%
13,562 $126,000
Q4 2022

Jan 30, 2023

SELL
$9.86 - $14.59 $98 - $145
-10 Reduced 0.07%
14,462 $152,000
Q3 2022

Nov 08, 2022

BUY
$13.1 - $20.34 $1,572 - $2,440
120 Added 0.84%
14,472 $262,000
Q2 2022

Aug 04, 2022

BUY
$12.37 - $21.86 $100,197 - $177,066
8,100 Added 129.56%
14,352 $203,000
Q1 2022

May 05, 2022

BUY
$15.94 - $23.34 $57,128 - $83,650
3,584 Added 134.33%
6,252 $138,000
Q4 2021

Feb 02, 2022

BUY
$14.76 - $24.89 $39,379 - $66,406
2,668 New
2,668 $45,000

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $292M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.